药物对比
Linagliptin vs Alogliptin
Linagliptin 与 Alogliptin：比较两种治疗2型糖尿病的DPP-4抑制剂，包括肾功能调整需求、心血管风险、血糖控制及安全性。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when selecting a DPP-4 inhibitor add-on therapy for type 2 diabetes, particularly in patients with varying degrees of renal function or cardiovascular disease.
结论
Both are effective similar DPP-4 inhibitors; Linagliptin may be more convenient for patients with reduced kidney function.
全部药物对比